Tyra Biosciences, Inc.
TYRA
$10.04
-$0.05-0.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.13M | 21.52M | 20.30M | 18.62M | 17.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 104.20M | 100.09M | 95.45M | 87.93M | 79.95M |
| Operating Income | -104.20M | -100.09M | -95.45M | -87.93M | -79.95M |
| Income Before Tax | -86.48M | -83.74M | -80.88M | -75.45M | -69.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -86.48 | -83.74 | -80.88 | -75.45 | -69.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -86.48M | -83.74M | -80.88M | -75.45M | -69.13M |
| EBIT | -104.20M | -100.09M | -95.45M | -87.93M | -79.95M |
| EBITDA | -103.68M | -99.62M | -95.02M | -87.54M | -79.59M |
| EPS Basic | -1.51 | -1.61 | -1.69 | -1.68 | -1.62 |
| Normalized Basic EPS | -0.94 | -1.00 | -1.06 | -1.05 | -1.01 |
| EPS Diluted | -1.51 | -1.61 | -1.69 | -1.68 | -1.62 |
| Normalized Diluted EPS | -0.94 | -1.00 | -1.06 | -1.05 | -1.01 |
| Average Basic Shares Outstanding | 228.83M | 212.74M | 196.73M | 180.65M | 170.82M |
| Average Diluted Shares Outstanding | 228.83M | 212.74M | 196.73M | 180.65M | 170.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |